Related Experiment Video
Updated: Feb 17, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
[Atherothrombosis : Novel therapeutic strategies]
O Soehnlein1,2,3
1Institute for Cardiovascular Prevention, Ludwig Maximilians University Munich, Pettenkoferstr. 9, 80336, München, Deutschland. oliver.soehnlein@gmail.com.
Insights
Atherosclerosis, a leading cause of death, is a multifactorial inflammatory disease, not just lipid-driven. This review covers current treatments and emerging therapies for atherosclerosis and atherothrombosis.
Area of Science:
- Cardiovascular Science
- Inflammation Biology
- Medical Research
Background:
- Atherosclerosis and atherothrombosis are primary global mortality causes.
- Recent findings reveal atherosclerosis as a multifactorial inflammatory process in large arteries, beyond lipid-driven mechanisms.
Purpose of the Study:
- To review the mechanistic basis of atherosclerosis.
- To summarize current therapeutic strategies for atherosclerosis.
- To outline novel therapeutic options under investigation.
Main Methods:
- Literature review of mechanistic studies on atherosclerosis.
- Synopsis of current clinical treatment strategies.
- Survey of ongoing clinical and experimental therapeutic trials.
Main Results:
- Atherosclerosis involves complex inflammatory pathways in arterial walls.
- Current treatments target lipid reduction and inflammation.
- Several new therapeutic avenues are in development.
Conclusions:
- Understanding atherosclerosis as an inflammatory disease is crucial for effective treatment.
- A multi-targeted approach is necessary for managing atherosclerosis and atherothrombosis.
- Ongoing research holds promise for improved therapeutic outcomes.
Abstract:
Despite intensive scientific research over the past decades, atherosclerosis and atherothrombosis are the leading cause of mortality worldwide. During the recent past it has become clear that atherosclerosis is not merely a lipid-driven disease but a multifactorial process involving chronic inflammation of large arteries. This review article briefly outlines the mechanistic nature of atherosclerosis, presents a synopsis of the current state of the art treatment strategies and finally outlines several therapeutic options, which are in clinical and experimental testing.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care
Angina IV: Management

